BMI1 Promotes Cholangiocarcinoma Progression and Correlates with Antitumor Immunity in An Exosome-Dependent Manner

Zengli Liu(Qilu Hospital of Shandong University), Zongli Zhang(Qilu Hospital of Shandong University)

Research Square

February 21, 2022

10.21203/rs.3.rs-1215808/v2

Cited by 0

Related Papers

Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma

|Cell Communication and Signaling|2020|64

Transcription factor 7 promotes the progression of perihilar cholangiocarcinoma by inducing the transcription of c-Myc and FOS-like antigen 1

|EBioMedicine|2019|62

IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma

|Oncotarget|2017|25